Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TZP-101 for postoperative ileus after major open abdominal surgery
2007-001715-36Phase 2Completed
- Sponsor
- Tranzyme Pharma
- Start
- May 2007
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ulimorelin in postoperative ileus (POI) (4 arms), sponsored by Tranzyme Pharma. Primary endpoint: Time to recovery of gastrointestinal function. Started May 2007; status: completed.
02
Drugs
ulimorelin
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on 2007-001715-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001715-36.